8-Hydroxyquinoline → HCID 89699972、化合物
反応式
Br[C:2]1[CH:3]=[C:4]([CH:8]=[C:9]([S:11]([F:16])([F:15])([F:14])([F:13])[F:12])[CH:10]=1)[C:5]([OH:7])=[O:6].[CH3:17][C:18]1[NH:19][CH:20]=[CH:21][N:22]=1.OC1C=CC=C2C=1N=CC=C2>CN(C=O)C.C(=O)(O)[O-].C([N+](CC)(CC)CC)C.[Cu]I>[CH3:17][C:18]1[N:19]([C:2]2[CH:3]=[C:4]([CH:8]=[C:9]([S:11]([F:16])([F:15])([F:14])([F:13])[F:12])[CH:10]=2)[C:5]([OH:7])=[O:6])[CH:20]=[CH:21][N:22]=1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 3
反応条件
- 温度
- 160 °C
実験手順
1.0 g (3.06 mmol) of the compound of Example 15A and 276 mg (3.36 mmol) of 2-methylimidazole were dissolved in 20 ml of DMF and 2 ml of water, and the mixture was degassed with argon. 2.06 g (6.42 mmol) of tetraethylammonium bicarbonate were added carefully, followed by 232 mg (1.22 mmol) of copper(I) iodide and 177 mg (1.22 mmol) of 8-hydroxyquinoline. The mixture was heated in a microwave oven (Biotage Initiator, with Dynamic Field Tuning) at 160° C. for 60 min. The reaction was then filtered, and the filtrate was adjusted at pH 1 with concentrated hydrochloric acid and concentrated under reduced pressure. The residue was separated into its components by preparative HPLC (Method 17). Evaporation of the product fractions and drying of the residue under high vacuum gave 238 mg (94% pure, 22% of theory) of the title compound.
後処理
- custom2 ml of water, and the mixture was degassed with argon
- filtrationThe reaction was then filtered
- concentrationconcentrated under reduced pressure
- customThe residue was separated into its components by preparative HPLC (Method 17)
- customEvaporation of the product fractions
- customdrying of the residue under high vacuum
出典と根拠
- ORDレコード
- ord-96a6f56361a04f6d845369da31940732
- 出典データセット
- uspto-grants-2016_07
- 特許番号
- US09394309B2
反応ノート
読み込み中…